Our findings highlight the oncogenic role of DKK1 in promoting HCC cell migration and invasion through activation of β-catenin/MMP7 signaling pathway, implicating that DKK1 may serve as a potential target for HCC therapy. This evidence concerns the gene MMP7 and hepatocellular carcinoma.